Thalys Medical Technology Group SHSE:603716 Rapport sur les actions Thalys Medical Technology Group Corporation
SHSE:603716 Rapport sur les actions
Capitalisation boursière : CN¥1.6b
603716 Aperçu des actions Thalys Medical Technology Group Corporation fournit des services intensifs d'inspection médicale en Chine.
Analyse des risques Voir tous les contrôles de risques Thalys Medical Technology Group Corporation Concurrents Historique des prix et performances
Résumé des plus hauts, des changements et des baisses de prix pour Thalys Medical Technology Group Historique des cours de bourse Prix actuel de l'action CN¥8.45 Plus haut sur 52 semaines CN¥13.10 Plus bas sur 52 semaines CN¥5.13 Bêta 0.76 1Variation sur 1 mois 19.35% Variation sur 3 mois 24.82% Variation sur 1 an -28.21% 3Variation sur 3 ans -42.91% Variation sur 5 ans -50.61% Évolution depuis l'introduction en bourse -23.68%
Nouvelles et mises à jour récentes
Third quarter 2024 earnings released: CN¥0.42 loss per share (vs CN¥0.033 loss in 3Q 2023) Oct 29
Wuhan Herun Ruihui Business Consulting Co., Ltd. agreed to acquire 80% stake in Wuhan Huixin Technology Development Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 72 million. Oct 02
Thalys Medical Technology Group Corporation to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement Aug 12
Thalys Medical Technology Group Corporation to Report First Half, 2024 Results on Aug 30, 2024 Jun 28 Thalys Medical Technology Group Corporation (SHSE:603716) announces an Equity Buyback for CNY 20 million worth of its shares. Jun 06
Voir plus de mises à jour
Third quarter 2024 earnings released: CN¥0.42 loss per share (vs CN¥0.033 loss in 3Q 2023) Oct 29
Wuhan Herun Ruihui Business Consulting Co., Ltd. agreed to acquire 80% stake in Wuhan Huixin Technology Development Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 72 million. Oct 02
Thalys Medical Technology Group Corporation to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement Aug 12
Thalys Medical Technology Group Corporation to Report First Half, 2024 Results on Aug 30, 2024 Jun 28 Thalys Medical Technology Group Corporation (SHSE:603716) announces an Equity Buyback for CNY 20 million worth of its shares. Jun 06
Thalys Medical Technology Group Corporation, Annual General Meeting, May 20, 2024 Apr 29
First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.07 loss in 1Q 2023) Apr 28
Thalys Medical Technology Group Corporation, Annual General Meeting, May 20, 2024 Apr 28
Thalys Medical Technology Group Corporation to Report Q1, 2024 Results on Apr 27, 2024 Mar 29 An undisclosed buyer acquired 51% stake in Shanxi Thalys Medical Technology Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 1.53 million.
Thalys Medical Technology Group Corporation (SHSE:603716) announces an Equity Buyback for CNY 20 million worth of its shares. Feb 08
Thalys Medical Technology Group Corporation to Report Fiscal Year 2023 Results on Apr 27, 2024 Dec 29
New major risk - Financial position Oct 27
Second quarter 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.099 loss in 2Q 2022) Aug 30
New minor risk - Share price stability Aug 10
Thalys Medical Technology Group Corporation to Report First Half, 2023 Results on Aug 30, 2023 Jun 28
First quarter 2023 earnings released: CN¥0.07 loss per share (vs CN¥0.10 profit in 1Q 2022) Apr 28
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released: CN¥0.016 loss per share (vs CN¥0.012 loss in 3Q 2021) Oct 27
Second quarter 2022 earnings released: CN¥0.099 loss per share (vs CN¥0.012 loss in 2Q 2021) Aug 17
Huang Jianfeng completed the acquisition of Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. Aug 12
Full year 2021 earnings: EPS and revenues exceed analyst expectations Apr 27
Less than half of directors are independent Apr 27
Second quarter 2021 earnings released: CN¥0.012 loss per share (vs CN¥0.18 profit in 2Q 2020) Aug 25
Investor sentiment improved over the past week Jun 05
First quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.12 loss in 1Q 2020) Apr 30
New 90-day low: CN¥14.45 Feb 03
New 90-day low: CN¥14.50 Jan 14
New 90-day high: CN¥17.71 Dec 16
New 90-day low: CN¥14.70 Nov 02
Third quarter earnings released Oct 30
Thalys Medical Technology Group Inc. to Report Q3, 2020 Results on Oct 30, 2020 Oct 29
New 90-day high - CN¥18.10 Sep 14
First half earnings released Aug 21
Thalys Medical Technology Inc. (SHSE:603716) agreed to acquire remaining 49% stake in Shanghai Thalys Medical Technology Co., Ltd. from Liu Hongkui and Zhang Luqi for CNY 0. Aug 06
New 90-day high - CN¥17.33 Jul 29 Rendement pour les actionnaires 603716 CN Biotechs CN Marché 7D 15.4% 6.9% 6.9% 1Y -28.2% -11.4% 10.3%
Voir le rapport complet des actionnaires
Rendement vs Industrie: 603716 a sous-performé le secteur CN Biotechs qui a rapporté -11.4 % au cours de l'année écoulée.
Rendement vs marché: 603716 a sous-performé le marché CN qui a rapporté 10.3 % au cours de l'année écoulée.
Volatilité des prix Is 603716's price volatile compared to industry and market? 603716 volatility 603716 Average Weekly Movement 8.2% Biotechs Industry Average Movement 8.7% Market Average Movement 7.9% 10% most volatile stocks in CN Market 12.2% 10% least volatile stocks in CN Market 5.4%
Cours de l'action stable: 603716 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de 603716 ( 8% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise Thalys Medical Technology Group Corporation fournit des services d'opérations intensives d'inspection médicale en Chine. La société était auparavant connue sous le nom de Thalys Medical Technology Inc. et a changé son nom en Thalys Medical Technology Group Inc. en septembre 2020. Thalys Medical Technology Group Inc. a été fondée en 2004 et son siège social se trouve à Wuhan, en Chine.
Afficher plus Thalys Medical Technology Group Corporation Résumé des fondamentaux Comment les bénéfices et les revenus de Thalys Medical Technology Group se comparent-ils à sa capitalisation boursière ? 603716 statistiques fondamentales Capitalisation boursière CN¥1.58b Bénéfices(TTM) -CN¥210.78m Recettes(TTM ) CN¥1.90b
Bénéfices et recettes Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM) 603716 compte de résultat (TTM ) Recettes CN¥1.90b Coût des recettes CN¥1.54b Marge brute CN¥357.14m Autres dépenses CN¥567.92m Les revenus -CN¥210.78m
Derniers bénéfices déclarés
Sep 30, 2024
Prochaine date de publication des résultats
s/o
Résultat par action (EPS) -1.13 Marge brute 18.83% Marge bénéficiaire nette -11.11% Ratio dettes/capitaux propres 96.1%
Quelles ont été les performances à long terme de 603716?
Voir les performances historiques et les comparaisons
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
